December 18, 2024 - Infowars.com reports: “On 12 December 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Kostaive, a vaccine intended for the prevention of COVID-19 in adults,” the ...

Infowars.com reports: “On 12 December 2024, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Kostaive, a vaccine intended for the prevention of COVID-19 in adults,” the ...

October 15, 2024 - Europe Approves New ‘Self-Replicating’ RNA Jabs That ‘Spread to Unvaccinated People' - The People's Voice

December 20, 2024 - 27 votes, 49 comments. 2.2M subscribers in the conspiracy community. This is a forum for free thinking and for discussing issues which have captured…

Regulatory Approval: The European Medicines Agency (EMA) has assessed & approved this new vaccine technology based on its safety & effectiveness profile, similar to how other vaccines are evaluated. The approval does not imply that the vaccine can or will spread to others.

January 23, 2025 - The European Union has authorized the use of a self-amplifying RNA vaccine, raising concerns about its ability to potentially spread beyond vaccinated individuals without consent.

September 2, 2022 - The vaccines are the first to target ... the first iteration of the virus that were approved by the EMA. The European Commission must still give its final approval, but this is expected to be given fairly swiftly....

November 13, 2024 - Europe has approved two drugs for preventing COVID-19 infection: a monoclonal antibody and a self-amplifying mRNA vaccine.

February 17, 2025 - CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for adults. This marks the first approval of an sa-mRNA COVID-19 vaccine by the European Commission, following its existing use in Japan.

December 17, 2024 - Self-replicating mRNA vaccines have received the greenlight from the European Committee for widespread use in Europe, despite alarming clinical trial results that included participant deaths and a staggering 90% reporting side effects.

December 16, 2024 - The European Committee for Medicinal Products for Human Use (CHMP) has recommended approving Kostaive, a self-replicating mRNA (saRNA) vaccine, despite significant safety concerns and lack of long-term data. Kostaive introduces a novel mechanism where injected mRNA replicates within the body, ...

A self-transcribing and replicating RNA (STARR)-based vaccine (LUNAR-COV19) has been developed to prevent SARS-CoV-2 infection. The vaccine encodes an alphavirus-based replicon and the SARS-CoV-2 full-length spike glycoprotein. Translation of the ...

December 15, 2024 - The Committee for Medicinal Products for Human Use has recommended marketing authorisation for Kostaive, a self-replicating mRNA (“saRNA”) injection developed by Arcturus Therapeutics. The final decision for regulatory approval now rests with the European Commission.

The initial round of COVID-19 vaccines were ineffective, dangerous and downright scary, but now Big Pharma has managed to come up with something even more terrifying: self-replicating RNA vaccines. Also known as replicon vaccines, they work by making copies of themselves endlessly and create ...

May 15, 2023 - In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

June 11, 2024 - In this article we cover A Self-Replicating RNA Vaccine: More than Just Increased Copy Number. Stay up to date on the latest in healthcare news and…

Self-replicating RNA viruses such as alphaviruses, flaviviruses, paramyxoviruses, and rhabdoviruses have been engineered as expression vectors for vaccine development. The prominent feature of self-

March 6, 2024 - Although mRNA-based vaccines have been studied since the 1990s, the success seen for mRNA-based COVID-19 vaccines presented a major boost for the whole field. Much attention has been paid to improving the stability and delivery of mRNA by structural and chemical modifications and the engineering ...

December 21, 2024 - This development marks a pivotal ... with the European Commission. Self-replicating mRNA vaccines, like Kostaive, are designed to enhance the immune response by allowing the mRNA to replicate within the body. While this approach is supposed to improve vaccine efficacy, it raises serious safety ...

Alphaviruses, flaviviruses, measles viruses and rhabdoviruses are enveloped single-stranded RNA viruses, which have been engineered for recombinant protein expression and vaccine development. Due to the presence of RNA-dependent RNA polymerase activity, subgenomic RNA can replicate close to ...